Lineage Cell Therapeutics...

0.41
-0.01 (-1.63%)
At close: Apr 17, 2025, 3:59 PM

Lineage Cell Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
9.5M 8.95M 14.7M 3.9M 773K 1.48M 1.42M 1.79M 2.25M
334K 671K 728K 1.43M 385K 412K 302K 168K 358K
9.16M 8.27M 13.97M 2.47M 388K 1.07M 1.11M 1.62M 1.89M
-21.48M -24.73M -22.52M -49.21M -26.45M -38.88M -41.8M -38.9M -58.97M
1.72M 1.63M 829K 2K 1.04M 1.69M n/a n/a n/a
-18.58M -23.28M -25.81M -43.27M -21.92M -19.23M -47.13M -23.29M 18.62M
-18.61M -21.49M -26.35M -38.56M -20.68M -11.83M -45.99M -19.98M 33.57M
18.17M 17.3M 22.51M 18.21M 15.57M 24.03M 24.73M 19.92M 28.43M
12.47M 15.71M 13.99M 33.91M 12.32M 17.95M 20.95M 24.02M 36.11M
n/a n/a -2.15M -445K -1.05M -2.04M -1.31M 1.45M -403K
30.64M 33.01M 36.49M 51.68M 26.84M 39.94M 42.11M 42.28M 60.86M
n/a n/a 5.18M n/a n/a 1.69M 10.87M 692K 747K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
30.98M 33.68M 37.22M 53.11M 27.22M 40.35M 42.41M 42.45M 61.22M
27K -1.8M 541K -4.71M -1.24M -7.41M -346K -37.29M -175.95M
200.19M 172.66M 169.79M 164.5M 150.04M 145.53M 126.9M 114.48M 97.32M
200.19M 172.66M 169.79M 164.5M 150.04M 145.53M 126.9M 114.48M 99.55M
-0.09 -0.12 -0.16 -0.23 -0.14 -0.08 -0.36 -0.17 0.35
-0.09 -0.12 -0.16 -0.23 -0.14 -0.08 -0.36 -0.17 0.34
-21.48M -24.04M -21.79M -48.34M -24.41M -38.88M -37.72M -37.36M -54.21M
-21.48M -24.73M -22.52M -49.21M -26.45M -38.88M -40.99M -40.66M -58.97M
n/a 692K 727K 887K 2.11M 3.13M 3.27M 3.3M 4.76M